VEO logo

VEO report on mutations and variation in publicly shared SARS-CoV-2 raw sequencing data, Report No. 2, 11 Mar. 2021

Saturday 13 Mar 21
|

Contact

Marion Koopmans
Coordinator of VEO, Co-coordinator of COMPARE
Erasmus Universitair Medisch Centrum Rotterdam
VEO submits the second report on mutations and variation in publicly shared SARS-CoV-2 raw sequencing data.

In its second report to the European Commission, VEO Consortium members summarize mobilisation and analysis of SARS-CoV-2 sequence data submitted to the European COVID-19 Data Platform in the context of the VEO project, which aims to develop tools and data analytics for pandemic and outbreak preparedness.

Summary:

  • Update on mobilisation of raw reads, now totaling sequencing data sets from 354,106 viral isolates from 60 countries, a 17% increase since the previous report (16 Feb. 2021).
  • The majority of data submitted is from a limited number of countries (UK and USA).
  • With the exception of the UK, there is a considerable delay in uploading data to the ENA. The majority of uploads deposited from 4 Jan. 2021 to 4 Mar. 2021 was from samples throughout 2020.
  • The analysis of recently submitted data with recent sampling dates shows the ability to detect variants of concern in the raw sequence data.
  • To make optimal use of the EU open data effort, member states need to be encouraged to start sharing raw sequence data as timely as possible.

News and filters

Get updated on news that match your filter.
https://www.veo-europe.eu/news/2021/03/veo-report-on-mutations-and-variation-in-publicly-shared-sars-cov-2-raw-sequencing-data-report-no-2-?id=295b1e0e-fb34-4ada-b8db-17c125b12971
16 OCTOBER 2021